Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

29.36
+0.74502.60%
Post-market: 29.450.0900+0.31%19:58 EDT
Volume:4.45M
Turnover:131.80M
Market Cap:3.30B
PE:-25.46
High:30.28
Open:29.19
Low:29.09
Close:28.62
Loading ...
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Major Issues Report

8-K - Current report
Oct 28, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2020

Major Issues Report

8-K - Current report
Aug 28, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2020

Major Issues Report

8-K - Current report
May 21, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 17, 2020

Major Issues Report

Current report, item 7.01
Feb 26, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 26, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]